Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study

References

• Absalan, A., Doroud, D., Salehi-Vaziri, M., Kaghazian, H., Ahmadi, N., Zali, F., Pouriavali's, M. H., & Mousavi-Nasab, S. D. (2020). Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19. Gastroenterology and Hepatology from Bed to Bench, 13(4), 355–360.
   PubMedGoogle Scholar
• Alavian, G., Kolahdouzan, K., Mortezazadeh, M., & Torabi, Z. S. (2021). Antiretrovirals for prophylaxis against COVID-19: A comprehensive literature review. Journal of Clinical Pharmacology, 61(5), 581–590. https://doi.org/10.1002/jcph.1788
   PubMed Web of Science ®Google Scholar
• Alshahrani, S. (2020). Aliskiren - A promising antioxidant agent beyond hypertension reduction. Chemico-Biological Interactions, 326, 109145. https://doi.org/10.1016/j.cbi.2020.109145
   PubMed Web of Science ®Google Scholar
• Altarejo Marin, T., Machado Bertassoli, B., Alves de Siqueira de Carvalho, A., & Feder, D. (2020). The use of aliskiren as an antifibrotic drug in experimental models: A systematic review. Drug Development Research, 81(1), 114–126. https://doi.org/10.1002/ddr.21610
   PubMed Web of Science ®Google Scholar
• Andrianov, A. M., Kornoushenko, Y. V., Karpenko, A. D., Bosko, I. P., & Tuzikov, A. V. (2021). Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease. Journal of Biomolecular Structure & Dynamics, 39(15), 5779–5791. https://doi.org/10.1080/07391102.2020.1792989
   PubMed Web of Science ®Google Scholar
• Angeli, F., Reboldi, G., Mazzotta, G., Poltronieri, C., & Verdecchia, P. (2012). Safety and efficacy of aliskiren in the treatment of hypertension: A systematic overview. Expert Opinion on Drug Safety, 11(4), 659–670. https://doi.org/10.1517/14740338.2012.696608
   PubMed Web of Science ®Google Scholar
• Balasubramaniam, M., & Reis, R. J. S. (2020). Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins. ChemRxiv: The Preprint Server for Chemistry. https://doi.org/10.26434/chemrxiv.12084822
   Google Scholar
• Bello, M., Martínez-Muñoz, A., & Balbuena-Rebolledo, I. (2020). Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA. Journal of Molecular Modeling, 26(12), 340. https://doi.org/10.1007/s00894-020-04600-4
   PubMed Web of Science ®Google Scholar
• Bhat, Z. A., Chitara, D., Iqbal, J., Sanjeev, B. S., & Madhumalar, A. (2021). Targeting allosteric pockets of SARS-CoV-2 main protease Mpro). Journal of Biomolecular Structure & Dynamics, 1–16. https://doi.org/10.1080/07391102.2021.1891141 Online ahead of print.
   Google Scholar
• Chen, Y. W., Yiu, C. B., & Wong, K. Y. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research, 9, 129. https://doi.org/10.12688/f1000research.22457.2
   PubMedGoogle Scholar
• Chtita, S., Belhassan, A., Aouidate, A., Belaidi, S., Bouachrine, M., & Lakhlifi, T. (2021). Discovery of potent SARS-CoV-2 inhibitors from approved antiviral drugs via docking and virtual screening. Combinatorial Chemistry & High Throughput Screening, 24(3), 441–454. https://doi.org/10.2174/1386207323999200730205447
   PubMed Web of Science ®Google Scholar
• Coto, E., Avanzas, P., & Gómez, J. (2021). The renin-angiotensin-aldosterone system and coronavirus disease 2019. European Cardiology, 16, e07. https://doi.org/10.15420/ecr.2020.30
   PubMed Web of Science ®Google Scholar
• Dallocchio, R. N., Dessì, A., De Vito, A., Delogu, G., Serra, P. A., & Madeddu, G. (2021). Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? European Review for Medical and Pharmacological Sciences, 25(5), 2435–2448. https://doi.org/10.26355/eurrev_202103_25285
   PubMed Web of Science ®Google Scholar
• Daoud, S., Alabed, S. J., & Dahabiyeh, L. A. (2021). Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies. Acta Pharmaceutica (Zagreb, Croatia), 71(2), 163–174. https://doi.org/10.2478/acph-2021-0016
   PubMed Web of Science ®Google Scholar
• De Luca, G., Cercek, M., Okkels Jensen, L., Bushljetikj, O., Calmac, L., Johnson, T., Gracida Blancas, M., Ganyukov, V., Wojakowski, W., von Birgelen, C., IJsselmuiden, A., Tuccillo, B., Versaci, F., Ten Berg, J., Laine, M., Berkout, T., Casella, G., Kala, P., López Ledesma, B., … Verdoia, M. (2021). Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry. Biomedicine & Pharmacotherapy, 138, 111469. https://doi.org/10.1016/j.biopha.2021.111469
   PubMed Web of Science ®Google Scholar
• De Meyer, S., Bojkova, D., Cinatl, J., Van Damme, E., Buyck, C., Van Loock, M., Woodfall, B., & Ciesek, S. (2020). Lack of antiviral activity of darunavir against SARS-CoV-2. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 97, 7–10. https://doi.org/10.1016/j.ijid.2020.05.085
   PubMed Web of Science ®Google Scholar
• Ding, W., Li, X., Wu, W., He, H., Li, Y., Gao, L., Gan, L., Wang, M., Ou, S., & Liu, J. (2018). [Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy]. Xi Bao yu Fen zi Mian yi Xue za Zhi = Chinese Journal of Cellular and Molecular Immunology, 34(10), 891–895.
   PubMedGoogle Scholar
• Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T., Lukacik, P., Owen, C. D., Resnick, E., Strain-Damerell, C., Aimon, A., Ábrányi-Balogh, P., Brandão-Neto, J., Carbery, A., Davison, G., Dias, A., Downes, T. D., Dunnett, L., Fairhead, M., Firth, J. D., Jones, S. P., … Walsh, M. A. (2020). Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nature Communications, 11(1), 5047. https://doi.org/10.1038/s41467-020-18709-w
   PubMed Web of Science ®Google Scholar
• Essam, M., Barakat, N., Elkashef, A., Awadalla, A., Behery, A. E., & Abdel-Maboud, M. (2021). Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney. Life Sciences, 265, 118811. https://doi.org/10.1016/j.lfs.2020.118811
   PubMed Web of Science ®Google Scholar
• Fu, L., Ye, F., Feng, Y., Yu, F., Wang, Q., Wu, Y., Zhao, C., Sun, H., Huang, B., Niu, P., Song, H., Shi, Y., Li, X., Tan, W., Qi, J., & Gao, G. F. (2020). Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nature Communications, 11(1), 4417. https://doi.org/10.1038/s41467-020-18233-x
   PubMed Web of Science ®Google Scholar
• Grahl, M. V. C., Alcará, A. M., Perin, A. P. A., Moro, C. F., Pinto, É. S. M., Feltes, B. C., Ghilardi, I. M., Rodrigues, F. V. F., Dorn, M., da Costa, J. C., Norberto de Souza, O., & Ligabue-Braun, R. (2021). Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2. Informatics in Medicine Unlocked, 23, 100539. https://doi.org/10.1016/j.imu.2021.100539
   PubMedGoogle Scholar
• Gressens, S. B., Leftheriotis, G., Dussaule, J. C., Flamant, M., Levy, B. I., & Vidal-Petiot, E. (2021). Controversial roles of the renin angiotensin system and its modulators during the COVID-19 pandemic. Frontiers in Physiology, 12(624052), 624052.
   PubMedGoogle Scholar
• Guo, Y., Zeng, J., Li, Q., Li, P., Luo, F. M., Zhang, W. Z., Lu, Y. X., Wang, Q., Zhang, W., Zeng, Z. P., & Liu, L. S. [ (2020). Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension. Zhonghua Nei Ke Za Zhi, 59(0), E011.
   PubMedGoogle Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280. https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Homans, S. W. (1990). A molecular mechanical force field for the conformational analysis of oligosaccharides: Comparison of theoretical and crystal structures of Man alpha 1-3Man beta 1-4GlcNAc. Biochemistry, 29(39), 9110–9118. https://doi.org/10.1021/bi00491a003
   PubMed Web of Science ®Google Scholar
• Hosseini, F. S., & Amanlou, M. (2020). Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study. Life Sciences, 258, 118205. https://doi.org/10.1016/j.lfs.2020.118205
   PubMed Web of Science ®Google Scholar
• Indu, P., Rameshkumar, M. R., Arunagirinathan, N., Al-Dhabi, N. A., Valan Arasu, M., & Ignacimuthu, S. (2020). Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. Journal of Infection and Public Health, 13(12), 1856–1861. https://doi.org/10.1016/j.jiph.2020.10.015
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748. https://doi.org/10.1006/jmbi.1996.0897
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., & Tirado-Rives, J. (1996). Monte Carlo versus Molecular Dynamics for conformational sampling. The Journal of Physical Chemistry, 100(34), 14508–14513. https://doi.org/10.1021/jp960880x
   Web of Science ®Google Scholar
• Jorgensen, W. L., & Tirado-Rives, J. (2005). Molecular modeling of organic and biomolecular systems using BOSS and MCPRO. Journal of Computational Chemistry, 26(16), 1689–1700. https://doi.org/10.1002/jcc.20297
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Ulmschneider, J. P., & Tirado-Rives, J. (2004). Free energies of hydration from a generalized Born model and an ALL-atom force field. The Journal of Physical Chemistry B, 108(41), 16264–16270. https://doi.org/10.1021/jp0484579
   Web of Science ®Google Scholar
• Kumar, D., Chauhan, G., Kalra, S., Kumar, B., & Gill, M. S. (2020). A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules. Bioorganic Chemistry, 104, 104326. https://doi.org/10.1016/j.bioorg.2020.104326
   PubMed Web of Science ®Google Scholar
• Lagant, P., Nolde, D., Stote, R., Vergoten, G., & Karplus, M. (2004). Increasing normal modes analysis accuracy: The SPASIBA spectroscopic force field introduced into the CHARMM program. The Journal of Physical Chemistry A, 108(18), 4019–4029. https://doi.org/10.1021/jp031178l
   Web of Science ®Google Scholar
• Meziane-Tani, M., Lagant, P., Semmoud, A., & Vergoten, G. (2006). The SPASIBA force field for chondroitin sulfate: Vibrational analysis of D-glucuronic and N-acetyl-D-galactosamine 4-sulfate sodium salts. The Journal of Physical Chemistry A, 110(39), 11359–11370. https://doi.org/10.1021/jp063862g
   PubMed Web of Science ®Google Scholar
• Mondal, M., Sarkar, C., Jamaddar, S., Khalipha, A. B. R., Islam, M. T., Mahafzah, A., & Mubarak, M. S. (2020). Evaluation of the binding affinity of anti-viral drugs against main protease of SARS-CoV-2 through a molecular docking study. Infectious Disorders Drug Targets. https://doi.org/10.2174/1871526520666201207124408
   Google Scholar
• Mourad, J. J., & Levy, B. I. (2020). Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Nature Reviews. Cardiology, 17(5), 313. https://doi.org/10.1038/s41569-020-0368-x
   PubMedGoogle Scholar
• Park, J., Lee, S. H., You, S. C., Kim, J., & Yang, K. (2021). Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea. PLoS One, 16(3), e0248058. https://doi.org/10.1371/journal.pone.0248058
   PubMed Web of Science ®Google Scholar
• Pickard, A., Calverley, B. C., Chang, J., Garva, R., Lu, Y., & Kadler, K. E. (2021). Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells. bioRxiv: The Preprint Server for Biology. https://doi.org/10.1101/2021.01.31.428851
   Google Scholar
• Ramya, K., Suresh, R., Kumar, H. Y., Kumar, B. R. P., & Murthy, N. B. S. (2020). Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules. Bioorganic & Medicinal Chemistry, 28(10), 115466. https://doi.org/10.1016/j.bmc.2020.115466
   PubMed Web of Science ®Google Scholar
• Raphael, V. P., & Shanmughan, S. K. (2020). Computational evaluation of the inhibition efficacies of HIV antivirals on SARS-CoV-2 (COVID-19) protease and identification of 3D pharmacophore and hit compounds. Advances in Pharmacological and Pharmaceutical Sciences, 2020, 8818008.
   PubMedGoogle Scholar
• Rashikh, A., Ahmad, S. J., Pillai, K. K., & Najmi, A. K. (2012). Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases. The Journal of Pharmacy and Pharmacology, 64(4), 470–481. https://doi.org/10.1111/j.2042-7158.2011.01414.x
   PubMed Web of Science ®Google Scholar
• Refaey, R. H., El-Ashrey, M. K., & Nissan, Y. M. (2021). Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study. Virology, 554, 48–54. https://doi.org/10.1016/j.virol.2020.12.008
   PubMed Web of Science ®Google Scholar
• Rut, W., Groborz, K., Zhang, L., Sun, X., Zmudzinski, M., Pawlik, B., Wang, X., Jochmans, D., Neyts, J., Młynarski, W., Hilgenfeld, R., & Drag, M. (2021). SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nature Chemical Biology, 17(2), 222–228. https://doi.org/10.1038/s41589-020-00689-z
   PubMed Web of Science ®Google Scholar
• Sargolzaei, M. (2021). Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study. Journal of Molecular Graphics & Modelling, 103, 107803. https://doi.org/10.1016/j.jmgm.2020.107803
   PubMed Web of Science ®Google Scholar
• Şen, S., & Üresin, A. Y. (2020). COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option? Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir, 48(7), 631–634.
   PubMed Web of Science ®Google Scholar
• Sepehrdad, R., Frishman, W. H., Stier, C. T., Jr., & Sica, D. A. (2007). Direct inhibition of renin as a cardiovascular pharmacotherapy: Focus on aliskiren. Cardiology in Review, 15(5), 242–256. https://doi.org/10.1097/CRD.0b013e318093e43a
   PubMedGoogle Scholar
• Shamsi, A., Mohammad, T., Anwar, S., AlAjmi, M. F., Hussain, A., Rehman, M. T., Islam, A., & Hassan, M. I. (2020). Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible implication in COVID-19 therapy. Bioscience Reports, 40(6), BSR20201256.
   PubMed Web of Science ®Google Scholar
• Simão, S., Santos, D. F., & Silva, G. A. (2017). Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells. Angiogenesis, 20(1), 175–181. https://doi.org/10.1007/s10456-016-9526-5
   PubMed Web of Science ®Google Scholar
• Staessen, J. A., Li, Y., & Richart, T. (2006). Oral renin inhibitors. Lancet (London, England), 368(9545), 1449–1456. https://doi.org/10.1016/S0140-6736(06)69442-7
   PubMed Web of Science ®Google Scholar
• Sturrock, B. R., Milne, K. M., & Chevassut, T. J. (2020). The renin-angiotensin system - A therapeutic target in COVID-19? Clinical Medicine (London, England), 20(4), e72–e75. https://doi.org/10.7861/clinmed.2020-0146
   PubMed Web of Science ®Google Scholar
• Torshin, I. Y., Namiot, V. A., Esipova, N. G., & Tumanyan, V. G. (2021). Numeric analysis of reversibility of classic movement equations and constructive criteria of estimating quality of molecular dynamic simulations. Journal of Biomolecular Structure & Dynamics, 39(11), 4066–4076. https://doi.org/10.1080/07391102.2020.1773927
   PubMed Web of Science ®Google Scholar
• Vergoten, G., Mazur, I., Lagant, P., Michalski, J. C., & Zanetta, J. P. (2003). The SPASIBA force field as an essential tool for studying the structure and dynamics of saccharides. Biochimie, 85(1–2), 65–73. https://doi.org/10.1016/S0300-9084(03)00052-X
   PubMed Web of Science ®Google Scholar
• Wang, C., Guo, D., Wang, Q., You, S., Qiao, Z., Liu, Y., Dai, H., & Tang, H. (2016). Aliskiren targets multiple systems to alleviate cancer cachexia. Oncology Reports, 36(5), 3014–3022. https://doi.org/10.3892/or.2016.5118
   PubMed Web of Science ®Google Scholar
• Wang, J. (2020). Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. Journal of Chemical Information and Modeling, 60(6), 3277–3286. https://doi.org/10.1021/acs.jcim.0c00179
   PubMed Web of Science ®Google Scholar
• Yeung, M. L., Teng, J. L. L., Jia, L., Zhang, C., Huang, C., Cai, J. P., Zhou, R., Chan, K. H., Zhao, H., Zhu, L., Siu, K. L., Fung, S. Y., Yung, S., Chan, T. M., To, K. K., Chan, J. F., Cai, Z., Lau, S. K. P., Chen, Z., … Yuen, K. Y. (2021). Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell, 184(8), 2212–2228. https://doi.org/10.1016/j.cell.2021.02.053
   PubMed Web of Science ®Google Scholar
• Zhao, Q., Shen, J., Lu, J., Jiang, Q., & Wang, Y. (2020). Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): An umbrella review of systematic reviews. BMC Cardiovascular Disorders, 20(1), 179. https://doi.org/10.1186/s12872-020-01442-z
   PubMed Web of Science ®Google Scholar